Medical Device CRO: Full-Service Clinical Research for EU & Global Markets
From study design to MDR certification, your dedicated European CRO partner for medical device clinical investigations. Led by former Notified Body assessors with 50+ device studies across 20+ countries.
How MDX Supports Medical Device Manufacturers
What Does a Medical Device CRO Do?
A medical device CRO (Contract Research Organization) is a specialized partner that designs, manages, and executes clinical investigations for medical device manufacturers. Unlike pharmaceutical CROs, which focus on drug trials governed by ICH-GCP, a medical device CRO operates under device-specific frameworks such as ISO 14155, EU MDR 2017/745, and FDA 21 CFR 812.
The distinction matters more than most manufacturers realize. Medical device clinical investigations have fundamentally different requirements: shorter development cycles, iterative device design during studies, different endpoint structures, and regulatory pathways (CE marking, 510(k), PMA) that demand specialized knowledge.
A qualified medical device CRO manages the entire clinical investigation lifecycle: from clinical strategy and study design, through ethics committee and competent authority submissions, site selection, patient recruitment, monitoring, data management, and medical writing, all the way to the final clinical investigation report and regulatory submission.
The critical question is not whether you need a CRO, but whether your CRO truly understands medical devices. As Alberto Bardají, MDx’s Head of Medical Devices and former Notified Body Senior Assessor, puts it: “The most common mistake we see is manufacturers choosing a CRO that is not fully specialized in medical devices. Study design that works for a drug trial does not generate the type of evidence Notified Bodies need for device certification. This leads to redesign, delays, and significantly increased costs.”
For a detailed framework on how to evaluate CRO partners, read our complete guide: Medical Device CRO: How to Qualify Your Clinical Partner by MDx President David Tomé.
Why MDx Is Your Ideal Medical Device CRO Partner in Europe
Most global CROs were built for pharmaceutical development. Their processes, SOPs, and team structures are designed around drug trials, and they adapt them for devices as an afterthought. MDx CRO was built from the ground up for MedTech. This is not a subtle distinction.
When a manufacturer brings a Class III implantable device to MDx, the approach is fundamentally different from what a generalist CRO would deliver:
1. Former Notified Body Expertise on Your Side
MDx’s medical device team is led by Alberto Bardají, a former Notified Body Senior Assessor and QMS Auditor. This means MDx doesn’t just prepare submissions, the team anticipates exactly what reviewers will look for, identifies gaps before submission, and reduces deficiencies and review cycles. The result: fewer queries, faster approvals.
2. ISO 14155-Native Processes
Many CROs claim ISO 14155 compliance but operate with processes adapted from pharmaceutical studies. MDx has device-specific SOPs fully aligned with ISO 14155 and EU MDR from day one. Every study is audit-ready from the start, not retrofitted for compliance at the end.
“One question every manufacturer should ask their CRO, but almost never does, is: How do you ensure compliance with ISO 14155 in practice?” says Alberto. “Gaps in compliance are often identified late, during audits or submissions, causing significant delays. We build compliance into the study from the beginning.”
3. Integrated Clinical + Regulatory + Certification Strategy
MDx aligns clinical investigation design with technical documentation, risk management, and Notified Body expectations simultaneously. This integrated approach is what enables ~20–30% faster timelines compared to industry benchmarks and a 100% MDR submission success rate for medical devices.
4. Multi-Country Submission Experience
MDx has submitted clinical investigation dossiers in 20+ countries, primarily across Europe. Whether your study needs sites in Germany, Spain, Italy, France, or beyond, MDx handles competent authority and ethics committee submissions with proven processes.
5. Proven Track Record Across Device Classes
With 50+ medical device clinical investigations managed, MDx’s experience spans the most demanding device categories:
- Class IIb and Class III implantable devices
- Cardiovascular (stents, catheters, stroke devices)
- Neurology (neurostimulation, monitoring)
- Ophthalmology
- Aesthetic and dermatology devices
- Digital health and Software as a Medical Device (SaMD)
- General surgery and minimally invasive technologies
6. Study Rescue Capability
MDx has rescued multiple medical device studies previously managed by other CROs. Common issues include weak regulatory strategy, misalignment between clinical investigation endpoints and device claims, and poor documentation. In each case, MDx redefined the clinical and regulatory strategy, realigned the Clinical Investigation Plan with technical documentation, and recovered study validity, enabling a clear path toward regulatory approval.
Our Medical Device CRO Services
Technical files, CERs, PMCF plans, and EUDAMED registrations for MDR compliance.
Clinical performance studies and analytical validation under IVDR and ISO 20916.
IEC 62366-compliant usability evaluations, formative and summative studies, human factors.
CDx development strategy, IVDR Annex XIV studies, FDA PMA pathway for CDx.
Regulatory training, workshops, and strategic consulting for MedTech teams.
SaMD classification, MDR/IVDR compliance, EU AI Act readiness.
Class III Implantable Device, MDR Certification
Challenge: A manufacturer needed to transition a Class III implantable device from MDD to MDR certification. There were significant gaps in clinical evidence and technical documentation, with high Notified Body scrutiny.
MDx Approach: Built a fully integrated clinical + regulatory + certification strategy. Aligned clinical evidence with Notified Body expectations. Strengthened the Clinical Evaluation Report, risk management files, and technical documentation.
Result: Successful MDR certification with zero major non-conformities. Avoided the delays typical of MDD-to-MDR transitions.
Frequently Asked Questions About Medical Device CROs
-
What is a medical device CRO?
A medical device CRO (Contract Research Organization) is a specialized company that designs, manages, and executes clinical investigations for medical device manufacturers. Unlike pharmaceutical CROs, a medical device CRO operates under device-specific regulations including ISO 14155, EU MDR 2017/745, and FDA 21 CFR 812. Services typically include clinical investigation management, Clinical Evaluation Reports (CERs), Post-Market Clinical Follow-Up (PMCF), technical documentation, and regulatory submission support.
-
What device classes and therapeutic areas does MDx cover?
MDx has managed 50+ clinical investigations primarily for Class IIb and Class III medical devices. Therapeutic areas include cardiovascular, neurology, ophthalmology, aesthetic/dermatology, digital health, SaMD, and general surgery. MDx also covers IVD devices under IVDR.
-
How does having former Notified Body assessors on the team benefit my project?
Former NB assessors anticipate exactly what reviewers look for in submissions, identify documentation gaps before filing, and help reduce deficiencies and review cycles. This translates to fewer queries, faster approvals, and significantly lower risk of rejection or delay during MDR certification.
-
In how many countries can MDx manage clinical investigations?
MDx has submitted clinical investigation dossiers in 20+ countries, primarily across Europe. This includes competent authority applications, ethics committee submissions, and site management across multiple EU member states.
-
Can MDx rescue a study that was previously managed by another CRO?
Yes. MDx has successfully rescued multiple medical device studies. Common issues include weak regulatory strategy, misalignment between study endpoints and device claims, and poor documentation. MDx redefines the clinical and regulatory strategy, realigns the investigation plan with technical documentation, and recovers study validity.
-
How long does a medical device clinical investigation typically take?
Timelines vary significantly depending on device class, study complexity, and number of countries. However, MDx typically achieves 20-30% faster timelines than industry benchmarks thanks to better first-time-right quality, fewer review cycles, and an integrated clinical-regulatory approach.
-
What is the difference between a medical device CRO and a regulatory consultant?
A regulatory consultant provides advisory services, strategy guidance, documentation review, or gap assessments. A full-service medical device CRO owns and executes deliverables: manages clinical investigations end-to-end, produces submission-ready documentation, and takes accountability for outcomes. For complex projects involving clinical evidence generation, a CRO’s integrated capability is essential.
Alberto Bardají | Head of Medical Devices
Alberto oversees medical device regulatory strategy, Notified Body and FDA interactions, and QMS support at MDx CRO. A former Notified Body Senior Assessor and QMS Auditor, he brings direct experience in evaluating device submissions from the reviewer’s perspective.
His expertise spans implantable devices (dental, orthopedics, trauma), active devices and software (SaMD), and complex MDR certification projects. Alberto works closely with clinical teams to ensure every study is designed to meet certification requirements from the outset.
Ready to Start Your Medical Device Clinical Investigation?
Contact our medical device team directly. Whether you’re planning a first-in-human study, navigating MDD-to-MDR transition, or need post-market support, our experts are ready to discuss your project.
